Srs Capital Advisors, Inc. Teva Pharmaceutical Industries LTD Transaction History
Srs Capital Advisors, Inc.
- $977 Million
- Q2 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 1,000 shares of TEVA stock, worth $17,460. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000Holding current value
$17,460% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TEVA
# of Institutions
604Shares Held
567MCall Options Held
25.2MPut Options Held
5.08M-
Black Rock Inc. New York, NY43MShares$751 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.3MShares$634 Million41.14% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L332.3MShares$565 Million5.5% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.29.1MShares$508 Million7.9% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$504 Million3.23% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $19.4B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...